You are here

A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
VA San Diego Healthcare System (Drug Shipment)
San Diego, California, 92161 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Type 1 Diabetes Mellitus
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Women and men age 18 and older.

- Diagnosis of type 1 diabetes within 2 years of randomization.

- Peak stimulated C-peptide levels ≥ 0.15 ng/mL.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Anticipated ongoing use of diabetes medications other than insulin.

- Evidence or history of diabetic complications with significant end-organ damage.

- Episode of severe hypoglycemia within 60 days of randomization.

- Multiple hospitalizations for diabetic ketoacidosis.

NCT02038764
Pfizer
Completed
A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now